BackAmerican Oncology Network- Warrants (20/09/2028) Overview
American Oncology Network Inc - Warrants (20/09/2028)

American Oncology Network- Warrants (20/09/2028) Return on Equity

Latest ROE for American Oncology Network- Warrants (20/09/2028): -40.67% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

-40.67%

Return on Equity

-40.67%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

American Oncology Network- Warrants (20/09/2028) (AONCW) FAQ

As of the most recent data, AONCW shows a ROE of -40.67%. That is below the sector sector average of -4.47%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about -4.47%. American Oncology Network- Warrants (20/09/2028) is at -40.67%, which is lower that average. That is roughly 810.3% below the sector mean. Use the comparison chart on this page to see how AONCW stacks up against individual peers as well.

Check the historical chart to see whether AONCW's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare American Oncology Network- Warrants (20/09/2028) with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has American Oncology Network- Warrants (20/09/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -40.67%) with ownership activity and broader fundamentals.